Logo

Top 10 Most-Read Articles for 2010 on GWDN

Dec 31, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – In a very busy year for news in the 'omics and molecular diagnostics industries, an article about an acquisition topped the list of the most-read stories for the year on GenomeWeb Daily News, while restructurings, lawsuits, and one firm's IPO plans made it into the top 10.

Here are the top 10 for the year:

1) Life Technologies CEO Defends Price for Ion Torrent, Dismisses Illumina's PCR System

2) Roche Restructuring Plan Includes 4,800 Job Cuts

3) Life Technologies to Acquire Ion Torrent for up to $725M

4) Affymetrix Sues Pacific Biosciences for Hiring Away Employees

5) Illumina Seeks to Solve PCR Reagents Puzzle

6) Federal Court Rules that Myriad's BRCA Patents are Invalid; Deems 'Isolated DNA' Unpatentable

7) More Genetic Test Firms Receive FDA Warnings

8) Applied Biosystems Sues Roche for Breach of Contract

9) Pacific Biosciences Files for IPO

10) Neandertal Genome Points to Human-Neandertal Interbreeding

Filed under

restructuring
lawsuit
IPO
mergers & acquisitions
Thermo Fisher Scientific
Roche
Illumina
Myriad
Pacific Biosciences
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.